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Estradiol (E2) robustly activates transcription of a broad array of genes in the hippocampal
formation of middle-aged ovariectomized rats via estrogen receptors (ERα, ERβ, and
G protein-coupled ER). Selective ERβ agonists also influence hippocampal functions,
although their downstream molecular targets and mechanisms are not known. In this
study, we explored the effects of long-term treatment with ERβ agonist diarylpropionitrile
(DPN, 0.05 mg/kg/day, sc.) on the hippocampal transcriptome in ovariectomized,
middle-aged (13 month) rats. Isolated hippocampal formations were analyzed by
Affymetrix oligonucleotide microarray and quantitative real-time PCR. Four hundred
ninety-seven genes fulfilled the absolute fold change higher than 2 (FC > 2) selection
criterion. Among them 370 genes were activated. Pathway analysis identified terms
including glutamatergic and cholinergic synapse, RNA transport, endocytosis, thyroid
hormone signaling, RNA degradation, retrograde endocannabinoid signaling, and mRNA
surveillance. PCR studies showed transcriptional regulation of 58 genes encoding
growth factors (Igf2, Igfb2, Igf1r, Fgf1, Mdk, Ntf3, Bdnf ), transcription factors (Otx2,
Msx1), potassium channels (Kcne2), neuropeptides (Cck, Pdyn), peptide receptors
(Crhr2, Oprm1, Gnrhr, Galr2, Sstr1, Sstr3), neurotransmitter receptors (Htr1a, Htr2c,
Htr2a, Gria2, Gria3, Grm5, Gabra1, Chrm5, Adrb1), and vesicular neurotransmitter
transporters (Slc32a1, Slc17a7). Protein-protein interaction analysis revealed networking
of clusters associated with the regulation of growth/troph factor signaling, transcription,
translation, neurotransmitter and neurohormone signaling mechanisms and potassium
channels. Collectively, the results reveal the contribution of ERβ-mediated processes
to the regulation of transcription, translation, neurogenesis, neuromodulation, and
neuroprotection in the hippocampal formation of ovariectomized, middle-aged rats and
elucidate regulatory channels responsible for DPN-altered functional patterns. These
findings support the notion that selective activation of ERβ may be a viable approach
for treating the neural symptoms of E2 deficiency in menopause.
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INTRODUCTION
17β-estradiol (E2) exerts profound effects in the brain including
the hippocampus (Gould et al., 1990). E2 increases dendritic
spine density of principal neurons during the estrous cycle
(Woolley et al., 1990), modulates both excitatory (Woolley et al.,
1997) and inhibitory (Murphy et al., 1998) neurotransmission,
enhances long-term potentiation (LTP) (Foy et al., 1999),
regulates neurogenesis (Tanapat et al., 1999), and attenuates
the innate immune response (Vegeto et al., 2003). E2 improves
cognitive performance in adult and middle-aged ovariectomized
(OVX) rats (Talboom et al., 2008; Rodgers et al., 2010) and
mice (Walf et al., 2008). These effects are mediated by the two
canonical intracellular receptors ERα, ERβ, and the membrane
G protein-coupled estrogen receptor GPER, which are expressed
in the hippocampal formation (Shughrue and Merchenthaler,
2000; Brailoiu et al., 2007; Mitterling et al., 2010; Waters et al.,
2015). The complex action of these receptors results in sensitive
responses of the female hippocampus to the cyclic changes of
serum E2 levels.
ERα and ERβ mediate the effects of E2 on both intracellular
signaling and gene transcription. They share similar domain
organization, and use almost identical DNA binding elements,
co-regulators, and transcription machinery (Gronemeyer et al.,
2004). The expression of the two receptors is not overlapping
(Shughrue et al., 1997), and differences in learning and
memory exist between ER knockout (ERKO) mice (Han et al.,
2013). ERαKO mice show reduced estrogen responsiveness and
impaired hippocampus-dependent memory (Foster et al., 2008).
ERβKO mice display attenuated hippocampal CA1 LTP and
related memory deficits (Day et al., 2005). The phenotypes
suggest distinct roles of ERα and ERβ in estrogen signaling.
Combinations of genetic and pharmacological approaches
have been successfully used to dissect the role of ERβ in the
regulation of hippocampal functions. Activation of ERβ with
a selective agonist WAY-200070 enhances LTP and synaptic
plasticity (Liu et al., 2008). E2 improves hippocampus-dependent
memory in wild type and ERαKO mice, but not in ERβKO
animals (Liu et al., 2008). Diarylpropionitrile (DPN) improves
cognitive performance in wild type, but not in ERβKO mice
(Walf et al., 2008). In rats, behavioral studies have shown
that DPN evokes anxiolytic effects (Walf and Frye, 2005)
and enhances performance in hippocampus-dependent memory
tasks (Rhodes and Frye, 2006; Pisani et al., 2016). These studies
suggest that ERβ agonists mimic many basic effects of E2 in
the hippocampus and enhance hippocampus-dependent spatial
memory (Rhodes and Frye, 2006; Jacome et al., 2010; Pisani et al.,
2012, 2016).
Human menopause is characterized by declining levels
of E2 that influence the performance of the hippocampal
formation (Weber et al., 2013). Symptoms may include anxiety,
mild depression, disturbances in contextual fear extinction,
impairment of spatial memory and regression of sexual behavior.
We have shown that in 13 months old OVX rats the hippocampal
transcriptome is highly responsive to timely E2 replacement
(Sarvari et al., 2015). In rodent menopause models, ERβ agonists
decrease anxiety (Walf and Frye, 2005; Hughes et al., 2008)
and depression (Clark et al., 2012; Suzuki et al., 2013), improve
memory (Jacome et al., 2010; Kiss et al., 2012), and modulate
fear extinction (Chang et al., 2009; Zeidan et al., 2011). Hence,
development of selective ERβ agonists may result in safe and
selective practice of hormone replacement therapy. The present
study was devoted to the aforementioned concept with the main
task to determine whether long-term DPN treatment of middle-
aged OVX rats has an impact on the hippocampal transcriptome




All experiments were performed with permission from the
Animal Welfare Committee of the Institute of Experimental
Medicine (IEM, Permission Number: A5769-01) and in
accordance with regulations of the European Community
(Decree 86/609/EEC). Female Harlan-Wistar rats were
purchased from Toxicoop (Budapest, Hungary) and housed
on a 12 h light/12 h dark cycle in the animal care facility of
IEM. The rats were used as breeders and retired at their age
of 8 months, and then housed individually for the subsequent
months. At their age of 13 months, rats were deeply anesthetized
and ovariectomized bilaterally (Sarvari et al., 2010). Afterward,
they were kept on phytoestrogen-free diet (Harlan Teklad
Global Diets, Madison, WI). Ten days later, Alzet 2004 osmotic
minipumps (DURECT, Cupertino, CA) filled either with DPN
(3.3 mg/ml in propylene-glycol, n = 8, DPN group) or vehicle
only (n = 8, control group) were implanted subcutaneously in
the scruff of the neck of the animals. This treatment lasted for 29
days providing a dosage of 0.02mg DPN/animal/day. The same
animals and hippocampal samples have been used in a recent
PCR study (Sarvari et al., 2014).
Affymetrix Rat Genome 230 PM Strip
Arrays
Hippocampal formations from 16 animals were prepared
and total RNA was isolated and analyzed as described
previously (Sarvari et al., 2014). RNA quality was measured
by capillary electrophoresis using 2100 Agilent Bioanalyzer
(Santa Clara, CA, USA) with Nano RNA chips. RNA samples
displayed high RNA integrity numbers (RIN > 8.2). Eight
samples were examined by oligonucleotide microarray, including
amplification, target labeling, hybridization, staining, and
scanning steps, which were carried out as described earlier
(Sarvari et al., 2015). In brief, 25 ng of total RNA Whole
Transcriptome Amplification (WTA) library preparation and
amplification for 17 cycles were performed following distributor’s
(Sigma-Aldrich) recommendations. Eight micrograms cDNA
was fragmented by DNAseI and biotinylated by terminal
transferase obtained from the GeneChip Mapping 250K
Nsp Assay Kit (Affymetrix Inc., Santa Clara, CA, USA).
Hybridization, washing, staining and scanning of Affymetrix
Rat Genome 230 PM Strip arrays were performed following
the manufacturer’s recommendations. Scanned images (DAT
files) were transformed into intensities (CEL files) using
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the AGCC software (Affymetrix). Data analysis, including
GCRMA, statistical and data mining work, were carried out
as published earlier (Sarvari et al., 2015). Gene Ontology
(GO) term enrichment was analyzed using public functional
annotation tools [DAVIDBioinformatics Resources; http://david.
abcc.ncifcrf.gov (Huang Da et al., 2009), and KEGG pathway
database; http://www.genome.jp/kegg]. Annotation clusters were
ranked by their score number, termed enrichment score,
calculated from the modified Fisher’s exact p-value of each GO-
term. Putative protein-protein interactions were evaluated by the
web-based STRING 10 platform (http://string-db.org).
Quantitative Real-Time PCR
Custom TaqMan microfluidic cards (Applied Biosystems, Foster
City, CA, USA) were designed to study mRNA expression by
real-time PCR. Sixteen samples were examined. One microgram
of total RNA was used for reverse transcription. Reverse
transcription and PCR were carried out by using Applied
Biosystems’ High Capacity cDNA Reverse Transcription Kit
and TaqMan Universal PCR Master Mix II, respectively. The
ViiA7 RUO 1.2.1 (Applied Biosystems) software and relative
quantification against calibrator samples (11Ct) were used
for data evaluation. Glyceraldehyde-3-phosphate dehydrogenase
(Gapdh) and hypoxanthine guanine phosphoribosyl-transferase
(Hprt) were used as housekeeping genes. Expression of these
genes did not vary among experimental groups. A computed
internal control corresponding to the geometric mean of cycle
threshold (Ct) values of Gapdh and Hprt was used for Ct
calculation. PCR data evaluation were performed as described
previously (Sarvari et al., 2014).
RESULTS
Effect of Long-Term DPN Administration
on Uterus Weight
Middle-aged, OVX rats received DPN at a dose of 20 µg/day,
subcutaneously via osmotic minipump for 29 days. At the end
of treatment, the potential proliferative threat on the uterus was
checked. The uterus weight of vehicle- and ERβ agonist-treated
rats were 205 ± 43.2 and 163 ± 30.0 mg, respectively, indicating
that DPN at this dose and treatment time did not induce cell
proliferation in the uterus.
Changes of the Hippocampal
Transcriptome in Response to Chronic
DPN Treatment
Microarray Study
Differential expression was studied in the hippocampal
formation by comparing vehicle- and ERβ agonist-treated
animals. We found that chronic treatment with DPN evoked
significant changes in the transcriptome. We considered a
gene regulated if the change of its transcription, i.e., the
modulus of its fold change (mFC), exceeded 2. Symbols and
description of regulated genes are listed in Supplementary
Table 1. Four hundred ninety-seven genes fulfilled the
mFC > 2.0 selection criterion. From these, 370 were activated
(Supplementary Table 2).
The top 59 upregulated and 11 downregulated genes, which
satisfied the mFC > 2.7 criterion, were listed in Table 1.
DPN robustly activated (FC > 4) the transcription of 18
genes including transthyretin (Ttr), claudin 2 (Cldn2), klotho
(Kl), insulin-like growth factor-binding protein 2 (Igfbp2),
secretoglobin (Scgb1c1), folate (Folr1), and prolactin (Prlr)
receptors, sclerostin domain containing (Sostdc1), small nuclear
ribonucleoprotein polypeptide G (Snrpg), prostaglandin D2
synthase (Ptgds), insulin-like growth factor 2 (Igf2), malectin
(Mlec), SEC63 homolog (Sec63), membrane frizzled-related
protein (Mfrp), spectrin beta, non erythrocytic 4 (Sptbn4),
midkine (Mdk), angiotensin I converting enzyme (Ace), and
poliovirus related receptor 1 (Pvrl). The single robustly
suppressed target gene (FC < 0.25) was stem-loop binding
protein (Slbp).
Heat Map Analysis
The heat map represents mRNA expression of the top 70
differentially expressed genes in the hippocampal formation of
vehicle treated (M-OVX) and DPN-treated (M-OVX+DPN)
animals (Figure 1). The heat map demonstrated that the
hippocampal transcriptome robustly responded to long-term
DPN treatment. The majority of transcriptional changes was
activation. The color-coded visualization of mRNA expression
levels displayed only small variability within the experimental
groups.
Functional Annotation of DPN-Regulated Genes
Pathway analysis and functional annotation clustering of DPN-
regulated genes were performed on web-based platforms, KEGG,
andDAVID v6.7 bioinformatics tool, respectively. KEGG analysis
(Table 2) identified terms related to neurotransmission including
glutamatergic synapse (Gng12, Dlgap1, Cacna1a, Shank2, Gls,
Gnbr, Kcnj3, Grm1, Grm8), cholinergic synapse (Chrm4, Gng12,
Pik3ca, Fos, Cacna1a, Chrm1, Gnbr, Kcnj3), RNA transport
(Tpr, Srrm1, Eif3d, Eif4g1, Thoc2, Eif3e, Upf3a, Nupl1, Pabpc1,
Ranbp2), endocytosis, thyroid hormone signaling pathway
(Hif1a, Pik3ca, Med1, Ncor1, Slc9a1, Crebbp, Pfkfb2, Atp2a2),
RNA degradation (Dhx36, Cnot6l, Edc4, Pabpc1, Ddx6, Lsm7),
retrograde endocannabinoid signaling (Gng12, Cacna1a, Mgll,
Mapk10, Gnbr, Kcnj3, Grm1), and mRNA surveillance pathway
(Papolg, Pabpn1, Srrm1, Upf3a, Cpsf3, Pabpc1). By the use
of STRING program, putative interactions of certain proteins
encoded by the DPN-regulated genes, obtained from the KEGG
pathway analysis, were revealed and plotted (Supplementary
Figure 1).
Another functional annotation tool (DAVID) identified
12 clusters with high enrichment score (ES), such as
membrane-enclosed lumen (ES = 4.39), mRNA metabolic
process (3.16), protein transport (2.24), nuclear mRNA
splicing (2.18), regulation of transcription (1.92), fatty acid
transport (1.47), regulation of carbohydrate metabolism
(1.45), nucleotide binding (1.44), potassium channel complex
(1.41), macromolecular complex assembly (1.41), vesicle
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TABLE 1 | List of DPN-regulated genes in the hippocampus.
Probeset ID LogFC FC P Adjusted Symbol Description
UPREGULATED GENES
1367598_PM_at 4.863 29.104 0.005 Ttr Transthyretin
1375933_PM_at 3.991 15.895 0.013 Cldn2 Claudin 2
1369361_PM_at 3.143 8.834 0.031 Kl Klotho
1367648_PM_at 3.105 8.602 0.015 Igfbp2 Insulin-like growth factor binding protein 2
1393436_PM_at 2.852 7.219 0.017 Scgb1c1 Secretoglobin, family 1C, member 1
1387889_PM_at 2.730 6.635 0.014 Folr1 Folate receptor 1 (adult)
1370789_PM_a_at 2.670 6.366 0.018 Prlr Prolactin receptor
1379281_PM_at 2.640 6.235 0.031 Sostdc1 Sclerostin domain containing 1
1372167_PM_at 2.325 5.009 0.008 Snrpg Small nuclear ribonucleoprotein poly peptide G
1367851_PM_at 2.313 4.968 0.007 Ptgds Prostaglandin D2 synthase (brain)
1367571_PM_a_at 2.305 4.940 0.032 Igf2 Insulin-like growth factor 2
1379046_PM_at 2.279 4.854 0.013 Mlec Malectin
1384519_PM_at 2.185 4.547 0.006 Sec63 SEC63 homolog (S. cerevisiae)
1377434_PM_at 2.173 4.509 0.047 Mfrp Membrane frizzled-related protein
1376564_PM_at 2.136 4.397 0.006 Sptbn4 Spectrin, beta, non-erythrocytic 4
1367682_PM_at 2.068 4.193 0.013 Mdk Midkine
1387791_PM_at 2.061 4.173 0.036 Ace Angiotensin I converting enzyme
1388215_PM_at 2.055 4.156 0.007 Pvrl1 Poliovirus receptor-related 1
1370844_PM_at 1.913 3.767 0.014 Hnrnpf Heterogeneous nuclear ribonucleoprotein F
1390532_PM_at 1.911 3.760 0.040 Slc13a4 Sodium/sulfate symporters
1371959_PM_at 1.891 3.710 0.005 Hist2h2aa3 Histone cluster 2, H2aa3
1374320_PM_at 1.838 3.575 0.061 F5 Coagulation factor V (proaccelerin)
1380475_PM_at 1.836 3.570 0.005 Gigyf2 GRB10 interacting GYF protein 2
1380549_PM_at 1.833 3.562 0.005 Ccar1 Cell division cycle and apoptosis regulator 1
1383386_PM_a_at 1.827 3.548 0.011 Sec3l1 SEC3-like 1 (S. cerevisiae)
1372893_PM_at 1.746 3.354 0.008 Yipf1 Yip1 domain family, member 1
1378971_PM_at 1.745 3.351 0.005 Mllt6 Myeloid/lymphoid or mix ed-lineage leukemia
1377061_PM_at 1.721 3.296 0.007 Arhgap32 Rho GTPase activating protein 32
1388244_PM_s_at 1.680 3.204 0.030 Rpsa Ribosomal protein SA
1379469_PM_at 1.669 3.180 0.006 Tbl1x Transducin (beta)-like 1 X-linked
1369568_PM_at 1.658 3.155 0.010 Stx6 Syntax in 6
1394343_PM_s_at 1.655 3.150 0.078 Kcne2 Potassium voltage-gated channel, Isk-related
1395053_PM_at 1.655 3.149 0.012 Pds5b PDS5, regulator of cohesion maintenance
1381537_PM_at 1.627 3.089 0.006 Klc3 Kinesin light chain 3
1390767_PM_at 1.611 3.055 0.006 Ssr1 Signal sequence receptor, alpha
1391312_PM_at 1.590 3.010 0.003 Inpp5f Inositol poly phosphate-5-phosphatase F
1382489_PM_at 1.586 3.003 0.009 Phip Pleckstrin homology domain interacting protein
1377997_PM_at 1.577 2.984 0.008 Agtpbp1 ATP/GTP binding protein 1
1390017_PM_at 1.571 2.972 0.016 Hapln2 Hyaluronan and proteogly can link protein 2
1390677_PM_at 1.571 2.971 0.020 Fibcd1 Fibrinogen C domain containing 1
1372916_PM_at 1.570 2.970 0.010 Mrps27 mitochondrial ribosomal protein S27
1388073_PM_a_at 1.561 2.950 0.010 Nupl1 Nucleoporin like 1
1376533_PM_at 1.536 2.900 0.010 Baz2b Bromodomain adjacent to zinc finger domain, 2B
1383418_PM_at 1.528 2.883 0.008 Adam11 ADAM metallopeptidase domain 11
Affx _Rat_Hex
_3_at
1.527 2.881 0.014 Hk1 Hexokinase 1
1381728_PM_at 1.501 2.830 0.005 Prkag2 Protein kinase, AMP-activ ated, gamma 2 subunit
1370800_PM_at 1.499 2.826 0.009 Slc9a1 Sodium/hydrogen exchanger
1379329_PM_at 1.498 2.824 0.010 Pcbd2 Pterin 4 alpha carbinolamine dehydratase
1393325_PM_at 1.484 2.797 0.006 Gtpbp6 GTP binding protein 6 (putative)
(Continued)
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TABLE 1 | Continued
Probeset ID LogFC FC P Adjusted Symbol Description
1375149_PM_at 1.483 2.796 0.005 Lrrc4b Leucine rich repeat containing 4B
1395913_PM_at 1.482 2.794 0.006 Acbd4 Acy l-CoA binding domain containing 4
1371335_PM_at 1.481 2.792 0.010 Atp5l ATP synthase, H+ transporting, mitochondrial Fo
1388568_PM_at 1.476 2.782 0.024 Eif3d Eukaryotic translation initiation factor 3, subunit
1374172_PM_at 1.474 2.778 0.049 Col8a2 Collagen, type VIII, alpha 2
1368729_PM_a_at 1.451 2.734 0.009 Adcyap1r1 Adenylate cyclase activating poly peptide 1
receptor
1388396_PM_at 1.450 2.731 0.007 Stk25 Serine/threonine kinase 25
1398487_PM_at 1.443 2.719 0.006 Pbx1 Pre-B-cell leukemia homeobox 1
1388531_PM_at 1.442 2.717 0.024 Pgrmc2 Progesterone receptor membrane component 2
1383920_PM_at 1.442 2.716 0.005 Amt Aminomethyltransferase
DOWNREGULATED GENES
1398355_PM_at −1.449 0.366 0.025 Trpm7 Transient receptor potential cation channel,
subfamily M
1371243_PM_at −1.451 0.366 0.011 Grm8 Glutamate receptor, metabotropic 8
1383192_PM_at −1.452 0.366 0.006 Spast Spastin
1388755_PM_at −1.461 0.363 0.011 Sec23a Sec23 homolog A (S. cerevisiae)
1395461_PM_at −1.493 0.355 0.005 Apc2 Adenomatosis polyposis coli 2
1383172_PM_at −1.507 0.352 0.007 Ranbp2 RAN binding protein 2
1389479_PM_at −1.569 0.337 0.009 Klf3 Kruppel-like factor 3 (basic)
1381859_PM_at −1.607 0.328 0.018 Fam91a1 Family with sequence similarity 91, member A1
1388689_PM_at −1.682 0.312 0.007 Acyp2 Acylphosphatase 2, muscle type
1390509_PM_a_at −1.913 0.265 0.013 Mrpl51 Mitochondrial ribosomal protein L51
1391387_PM_s_at −2.186 0.220 0.020 Slbp Stem-loop binding protein
Expression profiling using Affymetrix oligonucleotide microarray revealed that DPN regulates the hippocampal transcriptome in middle-aged, OVX rats. Using the fold change >2.7
selection criterion, the list of microarray data contains 59 up- and 11 downregulated genes.
coating (1.39), and DNA-dependent transcription (1.3) clusters
(Supplementary Table 3).
Quantitative Real-Time PCR Study of DPN-Regulated
Genes
We applied quantitative real-time PCR to confirm DPN-
dependent regulation of selected genes and to get further
insight to the impact of DPN on neurotransmission. We
selected 21 genes from the microarray gene list to confirm
regulation and 37 additional genes which are associated with
neurotransmitter and neuropeptide signaling. Selected genes and
changes in their mRNA expression are summarized in Table 3.
The PCR study revealed robustly and moderately regulated
genes. Robustly activated genes (RQ > 4.0; 17 genes) included
Sostdc1, Ttr, Kl, Prlr, Slco1a5, Mfrp, Aqp1, Otx2, Cldn2, Igfbp2,
Folr1, Igf2, Ace, Crhr2, Htr2c, Slc13a4, and Enpp2. Group of
moderately activated genes (4 > RQ > 1.2; 28 genes) contained
Cdkn1c, Kcne2, Cox8b, Fgf1, Mdk, Sfrp1, Msx1, Anxa2, Ptgds,
A2m, Aldh1a2, Mrc1, Slc12a2, Cdkn1a, Htr2a, Gpx1, Gria2,
Oprm1, Igf1r, Inpp5f, Ntf3, Gnrhr, Chrm5, Nr3c1, Grm5, Gria3,
Gphn, Gabra1. The group of downregulated genes coded for
neuropeptides (Pdyn, Cck), neuropeptide receptors (Sstr1, Sstr3,
Galr2), neurotransmitter receptors (Htr1a, Adrb1), vesicular
transporters (Slc17a7, Slc32a1), neurotrophic factor (Bdnf ),
and others (Gad1, Apoe, Atp2b4). Importantly, DPN-dependent
regulation of the 21 selected genes including Sostdc1, Ttr, Kl, Prlr,
Slco1a5,Mfrp, Aqp1, Otx2, Cldn2, Igfbp2, Folr1, Igf2, Ace, Htr2c,
Slc13a4, Enpp2, Kcne2, Mdk, Ptgds, Inpp5f, A2m was confirmed
by the PCR study.
Predicted Networking of Proteins Encoded
by DPN-Regulated Genes
Altogether, we identified 534 DPN-regulated genes by expression
profiling. We searched for interactions among proteins encoded
by these genes using the STRING 10 platform. At high
confidence level (0.72), STRING predicted a large number of
putative interactions and clusters composed of more than four
elements indicating that DPN may modulate multiple regulatory
mechanisms involved in hippocampal functions (Supplementary
Figure 2). STRING 10 analysis performed at the highest
confidence value (0.9) and filtering clusters for having more
than 3 interacting proteins, predicted interactions among 95
proteins (Figure 2). These 95 proteins form functional clusters
that may also network with each other. Five major clusters
emerged from the analysis. Cluster 1 contained 31 proteins
that are associated with transcription, mRNA metabolism,
splicing, and translation. This group networks with cluster 2
comprised of 26 intracellular signaling molecules and regulators
of transcription. The individual cluster 3 had five potassium
channel components. Cluster 4 is linked to cluster 2 and 5, and
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FIGURE 1 | Heat map. It depicts 70 differentially expressed genes in the hippocampus of middle-aged OVX rats treated for 29 days with vehicle or ERβ agonist DPN,
respectively. Rows represent DPN-regulated probe sets with corresponding gene symbols displayed on the right side of the figure. Transcription level of each probe is
color coded, the continuous color key is displayed in the upper right corner. Individual hippocampal samples of four vehicle (M-OVX)- and four DPN
(M+OVX+DPN)-treated animals are shown in columns.
included 13 growth/troph factors and related proteins. Cluster
5 contained 20, mostly G protein-coupled neurotransmitter and
neuropeptide receptors and neuropeptides. This cluster is wired
to cluster 4 via Pik3ca (and Trio).
A separate STRING analysis of down-regulated genes was
performed to take into account of transcriptional suppression
(Figure 3). Predicted interactions among proteins encoded by
suppressed genes showed Fos as the hub of the network. One
of the clusters was composed of proteins that are responsible
for neuropeptide (Pdyn, CCK, Sstr1, Sstr3, Bdkrb2) and
neurotransmitter (Htr1a, Grm8) signaling mechanisms. Another
cluster was related to neurotransmitter synthesis (Gad1, Gls) and
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TABLE 2 | Pathway analysis.
GO ID GO terms and corresponding genes Gene no. P P_fdr
4724 Glutamatergic synapse 9 4.68E-04 1.33E-01
Gng12, Dlgap1, Cacna1a, Shank2, Gls, Gnb5, Kcnj3, Grm1, Grm8
4725 Cholinergic synapse 8 1.51E-03 1.52E-01
Chrm4, Gng12, Pik3ca, Fos, Cacna1a, Chrm1, Gnb5, Kcnj3
3013 RNA transport 10 1.86E-03 1.52E-01
Tpr, Srrm1, Eif3d, Eif4g1, Thoc2, Eif3e, Upf3a, Nupl1, Pabpc1, Ranbp2
4144 Endocytosis 12 2.11E-03 1.52E-01
Asap1, Epn2, Arfgap1, Folr1, Vps45, Cxcr4, Nedd4, RT1-A1, Sh3gl2, Erbb4, Grk6, Vps4a
4919 Thyroid hormone signaling pathway 8 2.87E-03 1.63E-01
Hif1a, Pik3ca, Med1, Ncor1, Slc9a1, Crebbp, Pfkfb2, Atp2a2
3018 RNA degradation 6 4.68E-03 1.92E-01
Dhx36, Cnot6l, Edc4, Pabpc1, Ddx6, Lsm7
4723 Retrograde endocannabinoid signaling 7 4.69E-03 1.92E-01
Gng12, Cacna1a, Mgll, Mapk10, Gnb5, Kcnj3, Grm1
3015 mRNA surveillance pathway 8 1.07E-02 3.84E-01
Papolg, Pabpn1, Srrm1, Upf3a, Cpsf3,Pabpc1
Top GO terms of genes expressed differentially in the hippocampus of middle-aged OVX female rats treated with ERβ agonist DPN or vehicle as control. The analysis was performed
on the web-based KEGG platform. Terms were ranked based on their fdr values. Genes are listed at each GO term. Fdr, false discovery rate.
vesicular transport (Slc17a7, Slc32a1). Other clusters serve the
initiation of transcription via Fos.
DISCUSSION
Exploration of selective ERβ agonists has been pursued by the
academia and the pharmaceutical industry (Sun et al., 2003;
Liu et al., 2008; Clark et al., 2012) since the discovery of
the second ER (Kuiper et al., 1996). Molecular, morphological
and behavioral studies demonstrated beneficial impact of
ERβ agonists on hippocampal functions including anxiety,
learning and memory, but the underlying molecular mechanisms
remain poorly understood. To explore the impact of ERβ
agonists on hippocampal gene expression, we characterized
DPN-evoked transcriptional changes in OVX, middle-aged
female rats. We found that in this menopausal model, long-
term DPN treatment alters hippocampal gene expression,
activates several growth/troph factors, modifies transcription
and translation, modulates neurotransmitter and neuropeptide
signaling mechanisms and exerts neuroprotective effects.
Previous Expression Profiling Studies in
the Rodent Hippocampus
Estrogenic regulation of the hippocampal transcriptome has
already been investigated in mice (Han et al., 2013). Comparison
of basal and E2-induced gene expression profiles in wild-type and
ERKO mice has clarified the role of ERβ. ERβ exerts a regulatory
role on ERα-mediated gene expression and can substitute ERα
in the presence of higher levels of E2. The list of the top 30 genes
regulated by E2 in the hippocampus of middle-aged ERαKOmice
has been published (Han et al., 2013). Importantly, we found
12 overlapping top ERβ-regulated genes in the mouse and rat
hippocampus including Ttr, Otx2, F5, Sostdc1, Folr1, Cldn2, Kl,
Slc13a4, Enpp2, Ace, Kcne2, and Igf2.
We have previously examined the effect of treatments with
various ER agonists on the innate immune system of the
hippocampus in the same model (Sarvari et al., 2014). The
study revealed that DPN exerts many overlapping effects with
E2 and ERα agonist 16α-estradiol lactone, but there are clear
differences. In addition, it supports our previous finding that
estrogens regulate neuroinflammatory genes via ERα and ERβ
(Sarvari et al., 2011). In another study, we have explored the
impact of E2 replacement on the rat hippocampal transcriptome
and identified E2 target genes (Sarvari et al., 2015). Comparison
with DPN-regulated genes show that 38% of the top E2 target
genes also respond to chronic DPN treatment. Overlapping genes
include Ttr, Kl, Cldn2, Prlr, Sostdc1, F5, Igf2, Igfbp2, Slc13a4,
Folr1, Htr2c, Col8a2, Mfrp, Otx2, Ace, Mdk, Enpp2, Slco1a5,
Ptgds, Kcne2, Scgb1c1, A2m, Aqp1. This result demonstrates that
long-term DPN treatment partly mimics the genomic effects of
E2 replacement.
Chronic DPN Administration Affects
Neurotransmitter Signaling
GABA
GABAergic interneurons control local neuronal circuits in the
hippocampus (Freund and Buzsaki, 1996). Six GABAA receptor
α subunits (α1–α6) take part in the formation of GABAA
complexes. α1, α2, and α4 are found in all sectors of the
hippocampus (Wisden et al., 1992). GABAA receptor alpha1
subunit mRNA expression was found in CA1 and CA3 pyramidal
neurons and in granule cells (Wisden et al., 1992). Strong α1
immunostaining of GABAergic neurons was also characteristic.
All parvalbumin (PV) and half of calretinin interneurons express
α1, but calbindin, cholecystokinin (CCK) and VIP interneurons
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TABLE 3 | PCR Results.
Assay ID RQ P Symbol Gene name
Rn00596672_m1 182.9 0.034 Sostdc1 Sclerostin domain-containing protein 1
Rn00562124_m1 175.1 0.027 Ttr Transthyretin
Rn00580123_m1 141.4 0.040 Kl Klotho
Rn01525459_m1 76.08 0.020 Prlr Prolactin receptor
Rn01463516_m1 60.62 0.036 Slco1a5 Organic anion transporter
RN01417754_g1 49.54 0.053 Mfrp Membrane-type frizzled-related protein
Rn00562834_m1 47.95 0.031 Aqp1 Aquaporin
Rn01414596_m1 35.65 0.034 Otx2 Orthodenticle homeobox 2
Rn02063575_s1 13.32 0.044 Cldn2 Claudin 2
Rn00565473_m1 12.44 0.025 Igfbp2 Igf binding protein 2
Rn00591759_m1 12.41 0.029 Folr1 Folate receptor 1, adult
Rn01454518_m1 8.625 0.057 Igf2 Insulin-like growth factor 2
Rn00561094_m1 8.042 0.037 Ace Angiotensin converting enzyme
Rn00575617_m1 7.910 0.069 Crhr2 Corticotropin-releasing hormone receptor 2
Rn00562748_m1 7.223 0.061 Htr2c 5-Ht (serotonin) receptor 2c
Rn01747911_m1 6.756 0.027 Slc13a4 Sodium-dependent dicarboxylate transporter
Rn01505088_m1 4.694 0.027 Enpp2 Ectonucleotide pyrophosphatase
Rn01502044_g1 3.793 0.035 Cdkn1c Cyclin-dependent kinase inhibitor 1c
Rn02094913_s1 3.758 0.044 Kcne2 Potassium channel, voltage-gated, isk-related
Rn00562884_m1 3.600 0.058 Cox8b Cytochrome c oxidase, subunit VIIIb (Cox8b)
Rn00689153_m1 3.049 0.058 Fgf1 Fibroblast growth factor 1
Rn00675549_g1 2.889 0.024 Mdk midkine
Rn01478472_m1 2.777 0.088 Sfrp1 Secreted frizzled-related protein 1
Rn00667535_m1 2.412 0.066 Msx1 Muscle segment homeobox, drosophila,
homolog
Rn00571516_m1 2.293 0.052 Anxa2 Annexin a2
Rn00564605_m1 1.919 0.072 Ptgds Prostaglandin D2 synthase, brain
Rn00560589_m1 1.745 0.057 A2m Alpha-2-macroglobulin
Rn00588079_m1 1.626 0.078 Aldh1a2 Aldehyde dehydrogenase 1 family, member a2
Rn01487342_m1 1.576 0.065 Mrc1 Mannose receptor, c-type, 1
Rn00582505_m1 1.505 0.085 Slc12a2 Sodium/potassium/chloride transporter
Rn01427989_s1 1.502 0.036 Cdkn1a Cyclin-dependent kinase inhibitor 1a
Rn00568473_m1 1.440 0.018 Htr2a 5-Ht (serotonin) receptor 2a
Rn00577994_g1 1.368 0.039 Gpx1 Glutathione peroxidase
Rn00568514_m1 1.338 0.007 Gria2 Glutamate receptor, ionotropic, ampa 2
Rn01430371_m1 1.293 0.029 Oprm1 Opioid receptor, mu-1
Rn00583837_m1 1.265 0.055 Igf1r Insulin-like growth factor 1 receptor
Rn01508975_m1 1.252 0.066 Inpp5f Inositol polyphosphate 5-phosphatase f
Rn00579280_m1 1.243 0.045 Ntf3 Neurotrophin 3
Rn00578981_m1 1.241 0.049 Gnrhr GnRH receptor
Rn02758749_s1 1.237 0.052 Chrm5 Cholinergic receptor, muscarinic 5
Rn00561369_m1 1.236 0.074 Nr3c1 Nuclear receptor subfamily 3, group c, member 1
Rn00566628_m1 1.228 0.041 Grm5 Glutamate receptor, metabotropic 5
Rn00583547_m1 1.227 0.004 Gria3 Glutamate receptor, ionotropic, ampa 3
Rn00575867_m1 1.214 0.041 Gphn Gephyrin
Rn00788315_m1 1.208 0.091 Gabra1 GABA a receptor, subunit alpha 1
Rn00563215_m1 0.801 0.033 Cck Cholecystokinin
Rn00571351_m1 0.791 0.050 Pdyn Prodynorphin
Rn00561409_s1 0.773 0.018 Htr1a 5-Ht (serotonin) receptor 1a
Rn00824536_s1 0.756 0.034 Adrb1 Beta-1-adrenergic receptor
(Continued)
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TABLE 3 | Continued
Assay ID RQ P Symbol Gene name
Rn00593680_m1 0.748 0.026 Apoe Apolipoprotein E
Rn01483363_m1 0.720 0.036 Atp2b4 Atpase, ca(2+)-transporting, plasma membrane,
4
Rn00690300_m1 0.688 0.010 Gad1 67 kda glutamic acid decarboxylase - gad67
Rn00695901_g1 0.661 0.067 Galr2 Galanin receptor 2
Rn00824654_m1 0.600 0.002 Slc32a1 GABA vesicular transporter
Rn02531967_s1 0.580 0.003 Bdnf Brain-derived neurotrophic factor
Rn02134439_s1 0.576 0.002 Sstr3 Somatostatin receptor 3
Rn02532012_s1 0.463 0.029 Sstr1 Somatostatin receptor 1
Rn01462431_m1 0.366 0.012 Slc17a7 Vesicular glutamate transporter 1 - vglut1
Real-time PCR study revealed transcriptional regulation of 58 genes. Forty-five of them were upregulated. The DPN regulated genes code for neuropeptides, neurotransmitter and
neurohormone receptors, growth hormones, transcription factors, and transporters. RQ, relative quantity.
do not (Gao and Fritschy, 1994). We found that long-term ERβ
agonist treatment upregulates Gabra1 which encodes the α1
receptor subunit. Gephyrin, a scaffold protein anchors GABAA
receptors to postsynaptic cytoskeleton. The E domain of gephyrin
directly binds intracellular residues of 360–374 of α1 (Mukherjee
et al., 2011). DPN also upregulates Gphn.
Most GABAergic neurons utilize both isoforms of glutamic
acid decarboxylase (GAD) in the hippocampal formation
(Houser and Esclapez, 1994). GAD67 (GAD1) is spread evenly
in the cell, but GAD65 is localized to axon terminals indicating
that the former isoform produces GABA for basic cellular
processes, the latter for neurotransmission. Estrogenic regulation
of the expression of GAD isoforms at mRNA and protein
levels has been published (Nakamura et al., 2004). We showed
downregulation of Gad1 after chronic DPN treatment. At axon
terminals of inhibitory neurons, vesicular inhibitory amino acid
transporters (VIAAT) fill synaptic vesicles with GABA. The
transporter protein is highly expressed in the pyramidal and
granular layers of the hippocampus (Chaudhry et al., 1998).
VIAAT is coded by Slc32a1, which was downregulated by
DPN. These alterations predict a decrease in the inhibitory
tone within the hippocampal formation after long-term DPN
treatment.
Glutamate
Class I metabotropic glutamate receptors show a distinct pattern
of expression in the hippocampus. Metabotropic glutamate
receptor 1 (mGluR1) is mainly expressed in granule cells and
CA3 pyramidal neurons while mGluR5 is highly expressed
in all subfields of the rat hippocampus (Fotuhi et al., 1994).
We demonstrated that chronic DPN treatment enhances
transcription ofGrm1 andGrm5. Estrogenic regulation of AMPA
receptors at protein level has already been described in the rat
hippocampus (Waters et al., 2009). We found that DPN increases
mRNA expression of Gria2 and Gria3 coding for GluR2 and
GluR3 subunits of the AMPA receptor, respectively.
Glutaminase converts glutamine to glutamate in
glutamatergic neurons. Glutaminase IR is found in cell
bodies of principal neurons and sparsely, in axon terminals
in the rat hippocampus (Altschuler et al., 1985). Glutaminase
is also localized to astrocytes (Cardona et al., 2015). We
observed that DPN decreases glutaminase mRNA expression.
From the three known vesicular glutamate transporters
(vGLUT1-3), vGLUT1 is the main subtype expressed in the
hippocampus (Fremeau et al., 2004). It packs glutamate into
synaptic vesicles of the glutamatergic axon terminals. DPN
significantly inhibits transcription of Slc17a7 which codes
for vGLUT1. These findings indicate that long-term DPN
treatment decreases the release pool of glutamate in the
hippocampus.
Serotonin
The HT1A receptor is abundantly expressed in all CA sectors
and the dentate gyrus of rat hippocampus (Wright et al., 1995).
DPN modestly downregulates Htr1a. The two 5-HT2 receptors,
HT2A and HT2C show distinct expression patterns in the rat
hippocampus (Pompeiano et al., 1994). HT2A is expressed in
the CA3 sector, HT2C is expressed in the pyramidal cell layer
of CA3, the stratum oriens of CA1 and CA2. We showed that
both receptor genes (Htr2a, Htr2c) are activated in response to
DPN. Activation of HT2A receptors has been shown to decrease
the expression of BDNF in the granule cell layer without affecting
the CA subfields (Vaidya et al., 1997). HT2A receptor is in co-
localization with NR1 and GluR2 glutamate receptors residing
in dendrites of dentate gyrus neurons. To a lesser extent, the
receptor is also expressed in GABAergic interneurons of the
dentate gyrus.
Acetylcholine
Muscarinic acetylcholine receptors are G protein-coupled
receptors. M1 mediates primarily the effect of acetylcholine on
cognition, plasticity and neuronal excitability (Wei et al., 1994).
It has been suggested that expression of muscarinic receptor
subtypes depends on serum E2 levels (Cardoso et al., 2010).
In concert of this, we found that Chrm1 and Chrm5, which
encode M1 and M5, respectively, are upregulated by DPN. M5
is expressed in the hippocampus, especially in pyramidal cells of
CA1 (Vilaro et al., 1990).
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FIGURE 2 | Predicted interactions among proteins encoded by DPN-regulated genes. The network is based on the results of microarray and quantitative
real-time PCR studies and was constructed by using the STRING 10 Known and Predicted Protein-Protein Interactions program (http://string-db.org/) (see
(Continued)
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FIGURE 2 | Continued
Supplementary Figure 2). Analysis was performed at high confidence value (0.9), non-interacting elements were excluded. Selected protein clusters of the network are
depicted. Cluster 1: mRNA metabolism, splicing and translation; Cluster 2: regulation of transcription (red elliptic line highlights the relationship of Crebbp, Mapk8p2,
Mapk10, Fos and Jun); Cluster 3: components of potassium channels; Cluster 4: growth/troph factors; Cluster 5: peptides, neurotransmitter and neuropeptide
receptors.
FIGURE 3 | Predicted interactions among proteins encoded by downregulated genes. Network composed of proteins whose coding genes were
downregulated by long-term DPN treatment. STRING analysis, high confidence value (0.9).
Catecholamines
β1-adrenoceptors are expressed in the brain including CA1,
CA3, and dentate gyrus of the hippocampus (Vizi and Kiss,
1998; Paschalis et al., 2009). Beta 1 adrenergic receptor
(Adrb1) expression has been described in somatostatin and PV
interneurons of the CA1 and CA3 regions (Cox et al., 2008).
Long-term DPN treatment slightly downregulates Adrb1.
Modulation of Peptidergic Signaling
Cholecystokinin
The gut peptide CCK is also synthesized in the brain (Innis
et al., 1979). The rat hippocampus contains a great number
of CCK neurons predominantly located in CA1-2 regions and
dentate gyrus (Savasta et al., 1988). CCK-containing terminals
are located mainly in the CA1 and dentate gyrus (Handelmann
et al., 1981). CCK interneurons represent 10% of GABAergic
cells in the hippocampus (Kosaka et al., 1985). We found that
DPN suppresses mRNA expression of Cck. The finding is in
agreement with the decreased GABAergic tone seen after chronic
DPN administration.
Prodynorphin
Prodynorphin is a precursor of multiple opioid peptides
including dynorphin A. After proprotein convertase cleavage,
released peptides are stored in large dense-core vesicles in
synaptic terminals. Dynorphins, localized primarily to dental
granule cells (McGinty et al., 1983), modulate mossy fiber
signaling via presynaptic receptors (Weisskopf et al., 1993). We
showed that DPN downregulates PdynmRNA expression.
Angiotensin II
Angiotensin II is produced by angiotensin converting enzyme
(ACE) from angiotensin I. The rat hippocampus contains high
level of angiotensin II (Sirett et al., 1981). Angiotensin II
excites CA1 pyramidal cells by disinhibition (Haas et al., 1980).
Frontiers in Cellular Neuroscience | www.frontiersin.org 11 June 2016 | Volume 10 | Article 149
Sárvári et al. DPN Regulates Hippocampal Gene Expression
Upregulation of Ace is likely to increase the level of angiotensin
II after DPN treatment in the hippocampus.
Somatostatin Receptors
Somatostatin receptor (SSTR) subtypes show wide, distinct
but partially overlapping expression in the rat brain including
the hippocampus (Kong et al., 1994; Senaris et al., 1994).
Somatostatin controls excitatory neurotransmission in the
hippocampus via SSTR1 (Cammalleri et al., 2009). SSTR3 mRNA
expression has also been reported in the hippocampus (Kong
et al., 1994). The receptor protein is associated with cilia of
neurons located in the dentate gyrus and CA sectors (Handel
et al., 1999). Both Sstr1 and Sstr3 are downregulated by DPN.
µ-Opioid Receptor
Opioids primarily target interneurons in the hippocampal
formation (Zieglgansberger et al., 1979). Accordingly, µ-opioid
receptor IR is localized to multipolar cells in the granular and
pyramidal cell layers. High µ-receptor mRNA expression was
observed exclusively in GABAergic interneurons (Stumm et al.,
2004), and only those that innervate pyramidal cell bodies express
µ-opioid receptors (Svoboda et al., 1999). Estrogenic regulation
of the receptor has been suggested (Martini et al., 1989). We
found that DPN modestly activated transcription of Oprm1.
Prolactin Receptor
Prolactin receptor (PRL-R) is expressed throughout the rat brain
(Bakowska and Morrell, 1997; Pi and Grattan, 1998), but the
amount of PRL-R mRNA is low in the cerebral cortex (Nagano
and Kelly, 1994). We observed robust activation of Prlr in the
hippocampus after DPN treatment. Prolactin exerts protective
effects on the hippocampus against excitotoxicity (Morales et al.,
2014) and increases the number of precursor cells (Walker et al.,
2012). In PRL-R KO mice, there was an 80% decrease in the
number of hippocampus-derived neurospheres and the animals
showed learning and memory deficits (Walker et al., 2012).
Prolactin has been shown to prevent the decrease of neurogenesis
evoked by chronic stress (Torner et al., 2009). Of note, prolactin
is synthesized in the rat hippocampus independently from the
anterior pituitary (Emanuele et al., 1992).
Gonadotropin Releasing Hormone Receptor
Gonadotropin releasing hormone (GnRH) receptor is expressed
in the rat hippocampus (Badr and Pelletier, 1987). GnRH
receptors are localized to pyramidal cells of CA1, CA3, and
granule cells of the dentate gyrus, respectively (Jennes et al.,
1995). Expression of GnRH receptor varies during the estrous
cycle, with highest expression in proestrous (Savoy-Moore
et al., 1980). We found increased mRNA expression of Gnrhr
after DPN administration. GnRH administration has been
reported to change the electrophysiological properties of CA1
neurons (Wong et al., 1990) and regulate spine density in the
hippocampus (Prange-Kiel et al., 2008).
Galanin Receptors
Two galanin receptor (GalR) subtypes mediate the protective
and trophic effects of galanin in the hippocampus. GalR1 and
GalR2 are predominantly expressed in the CA1 subfield and the
dentate gyrus, respectively (Gustafson et al., 1996; Depczynski
et al., 1998). The hippocampus receives galaninergic innervations
from the septum-basal forebrain complex (Melander et al., 1985).
DPN downregulatesGalr2 in the hippocampus. Galanin receptor
2 interacts with neuropeptide Y Y1 receptor in the dentate gyrus
and contributes to an antidepressant effect (Narvaez et al., 2015).
Corticotropin-Releasing Hormone Receptor 2
Corticotropin-releasing hormone (CRH) receptors are found
in the rat hippocampus (Van Pett et al., 2000). The robust
downregulation of its expression has recently been reported in
rat hippocampus under chronic stress paradigm (Li et al., 2013).
We found that DPN enhances mRNA expression of Crhr2.
PACAP Receptor 1
PAC1, one of the three receptors for adenylate cyclase activating
polypeptide (PACAP), is expressed in the hippocampus (Zhou
et al., 2000). PACAP regulates phosphorylation of AMPAR
primarily via PAC1, which in turn modulates AMPAR function
and synaptic plasticity (Toda and Huganir, 2015). PACAP shows
neuroprotective activity in various experimental models (Reglodi
et al., 2000). PACAP and PAC1 are also involved in the regulation
of neurodevelopment (Vaudry et al., 1999). PAC1 is expressed
in a sex-specific manner during development (Shneider et al.,
2010). DPNmodestly activates transcription ofAdcyap1r1 coding
for PAC1.
Bradykinin Receptor 2
B2 bradykinin receptor is widely expressed in neurons of
the rat brain including the hippocampal formation (Chen
et al., 2000). Bradykinin, released after tissue injury, specifically
activates the B2 receptor (Albert-Weissenberger et al., 2013).
The receptor increases the excitability of the hippocampus and
its susceptibility to seizure (Rodi et al., 2013). We showed
downregulation of Bdkrb2.
Control of Potassium Channels
Voltage-gated potassium channels play an indispensable
role in the transition from depolarized to resting state of
neurons. For potassium channel coding genes refer to:
www.genenames.org/genefamilies/KCN. DPN treatment
modulates mRNA expression of genes coding for various
voltage-gated potassium channel alfa subunits and a single beta
subunit. Alfa subunits include delayed rectifier Kcna6 (Kv1.6)
and Kcnc2 (Kv3.2), and A-type Kcnd3 (Kv4.3) family members.
The single modulatory beta subunit is Kcne2. DPN strongly
activates transcription of Kcne2which is in line with the presence
of estrogen response elements in the promoter region of the
gene (Kundu et al., 2008). DPN modestly regulates Ca-activated
potassium channel (Kcnma1), inwardly rectifying channel
(Kcnj3), and tetramerization domain-containing 1 (Kctd1). With
the exception ofKcnk2 andKctd4, the DPN-controlled potassium
channel coding genes were upregulated. Increased expression
of Kcne2 may result in modulation of neuronal excitability via
KCNQ2-KCNQ3 channel function in the hippocampus (Tinel
et al., 2000).
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Effects on Growth/Troph Hormone
Signaling
Insulin-Like Growth Factor System
IGF2 is abundantly expressed in the rat hippocampus compared
to peripheral organs (Ye et al., 2015). IGF2 is a potent regulator
of adult hippocampal neurogenesis (Bracko et al., 2012) and
memory consolidation (Chen et al., 2011). We found that DPN
robustly activated mRNA expression of Igf2. DPN also enhanced
mRNA expression of Igfbp2 and Igf1r, which are involved in the
transport and recognition of IGF2, respectively. IGF1R mediates
the effects of serum IGF1 on modulation of synaptic plasticity
and hippocampal neurogenesis (Llorens-Martin et al., 2009).
Disruption of Igf1 heavily influences brain development and
results in loss of hippocampal granule cells (Beck et al., 1995).
Brain Derived Neurotrophic Factor
Brain derived neurotrophic factor (BDNF) mRNA is localized in
neurons of the pyramidal cell layer, the granular layer and the
hilus of the dentate gyrus (Wetmore et al., 1990). BDNF signaling
has a pivotal role in hippocampal neuroprotection, neurogenesis,
and affects depression-associated behaviors (Taliaz et al., 2010).
BDNF mRNA expression in the hippocampus fluctuates across
the estrous cycle and increases in response to E2 (Gibbs, 1998).
DPN moderately decreases mRNA expression of Bdnf.
Fibroblast Growth Factor
Fgf1 encodes acidic fibroblast growth factor which is synthesized
by the brain vasculature and can induce proliferation of
progenitor cells. FGF1 mRNA is also found in the pyramidal cell
layer and dentate granule cells of the rat hippocampus (Wilcox
and Unnerstall, 1991), although the number of FGF1-IR neurons
is rather low in the hippocampus (Stock et al., 1992). We found
that DPN moderately activates transcription of Fgf1.
Midkine
Midkine is a heparin-binding growth factor which is widely
expressed in the developing nervous system. It is expressed in
NSPCs and enhances their growth and survival (Zou et al., 2006).
The expression of midkine is limited to a few cell types in the
adult brain (Bloch et al., 1992). DPNmoderately upregulatesMdk
expression.
Increase of Klotho Signaling
Klotho is a pleiotropic gene the overexpression of which extends
lifespan in mice (Kurosu et al., 2005). Klotho is highly expressed
in the choroid plexus and in neurons of the hippocampus
(Kuro-o et al., 1997). It encodes a type I membrane protein
which can be cleaved by metalloproteases and released from
the cell membrane. Klotho promotes FGF-23 signaling, inhibits
insulin/IGF1 signaling and regulates Ca++ homeostasis (Imura
et al., 2007). In mice, systemic overexpression of klotho improves
learning and memory, and elevates synaptic NR2B in a subunit-
specific manner through posttranscriptional mechanism (Dubal
et al., 2014). We demonstrated that DPN robustly activates
mRNA expression of klotho.
Regulation of Transcription
The homeobox-containing transcription factor Otx2 plays an
indispensable role in normal brain development, but its role is
enigmatic in adulthood. The passage of Otx2 between cells by
non-conventional mechanism gives another layer of complexity
to the mechanism of action of Otx2 (Prochiantz and Theodore,
1995). Accumulation of Otx2 is required for the maturation of
PV-containing interneurons (Sugiyama et al., 2008). Long-term
DPN treatment highly activates mRNA expression of Otx2 which
may influence hippocampal plasticity. DPN also increases mRNA
expression of serum response factor (Srf), myelin transcription
factor 1 (Myt1), muscle segment homeobox (Msx1), pre-B cell
leukemia homeobox (Pbx1), transcription factor 12 (Tcf12), and
mediator 1 (Med1). Srf controls activity-dependent immediate-
early gene expression and synaptic strength in CA1 pyramidal
neurons (Ramanan et al., 2005). Mice with deletion of Srf
in the forebrain show impaired LTD and selective deficit in
explicit spatial memory (Etkin et al., 2006). These findings
suggest a crucial role for Srf in learning. Myt1 is expressed in
neural progenitors and oligodendrocytes, and is likely to regulate
oligodendrocyte differentiation (Armstrong et al., 1995). In the
hippocampus, Msx1 is localized to astrocytes, oligodendrocytes,
and immature oligodendrocytes (Ramos et al., 2004). Pbx1 is
highly expressed in the developing rat brain and its expression
is maintained in TuJ1-IR postmitotic neurons (Redmond et al.,
1996). We showed that DPN decreases mRNA expression of
Fos, which is in line with the presence of an estrogen response
element-like sequence in its promoter region (Cattaneo and
Maggi, 1990).
Cyclin-dependent kinases (Cdk) form complexes with cyclins
and operate as transcription factors. Depletion of Cdk10 impairs
progenitor cell survival (Yeh et al., 2013), therefore DPN-
evoked upregulation of Cdk10 may improve neural stem and
progenitor cell (NSPC) survival. Deletion of Cdkn1c initially
causes increased neurogenesis, while on the long run leads to
impaired neurogenesis in the hippocampus (Furutachi et al.,
2013). We found that DPN enhances Cdkn1cmRNA expression.
DPN inversely modulates the transcription of coregulators,
activates Ncor1 and suppresses Crebbp and Ncoa6, among
others. DPN also activates the transcription of Polr2b encoding
DNA-directed RNA polymerase II polypeptide B. DPN can
affect mRNA splicing and metabolism by upregulating splicing
factors (Sfrs11, Srrm1), spliceosome components (Snrpg) and
ribonucleoproteins (Hnrnpd, Hnrnpf, Prpf3). These findings




In females, structure and function of the tri-synaptic circuit
of the hippocampal formation is responsive to changes of
gonadal hormone levels. The neuronal response to E2, which
takes place within 15 min, includes dendritic remodeling and
synaptic turnover. The role of fast, nongenomic effects has
been explored and recognized, while the role of genomic
effects has remained unexplored. This study demonstrates that
selective activation of ERβ leads to robust alteration of mRNA
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expression of growth/troph factor genes and modest changes of
neurotransmitter and peptide receptor genes.
In the hippocampus, AMPA-type glutamate receptors
(AMPAR) are composed of GluR1/2 and GluR2/3 heterodimers.
As AMPAR mediates the majority of fast synaptic transmission,
the modulation of its composition and phosphorylation control
synaptic strength and cell firing (Huganir and Nicoll, 2013).
Upregulation of genes coding for AMPA receptor subunits
GluR2 (Gria2) and GluR3 (Gria3) may increase constitutive
insertion of GluR2/3 heterodimers shifting the composition
of synaptic AMPA receptors. The DPN-evoked increase of
GluR2 content may reduce Ca++ influx and decrease the
potential of excitatory events (Hume et al., 1991). The level
and site of GluR1 phosphorylation are regulated by various
receptors including β-adrenergic receptor, m1 acetylcholine
receptor (Seol et al., 2007) and PAC1 (Toda and Huganir,
2015), among others. Alterations in the expression of these
receptors may affect phosphorylation state of GluR1. In addition,
downregulation of vesicular glutamate transporter 1 (Slc17a7)
suggests a decreased synaptic glutamate pool in pyramidal and
dentate granule cells. We also showed significant suppression
of vesicular GABA transporter (Slc32a1) expression which
indicates a decreased inhibitory tone in the hippocampus after
chronic DPN treatment. Decreased Cck expression implicates
CCK interneurons in the alterations related to inhibitory
neurotransmission.
Neurogenesis
Neuronal plasticity also includes replacement of nonfunctional
cells by the proliferation, differentiation and migration of
NSPCs in the adult hippocampus. Proliferating (Ki-67+) and
migrating (DC+) cells of the dentate gyrus express ERβ and
ERα mRNA (Isgor and Watson, 2005). Extranuclear ERβ is
localized to DC-containing cells in the dentate gyrus of adult rats
(Herrick et al., 2006). Various laboratories have demonstrated
that selective ERβ agonists promote neurogenesis in the dentate
gyrus (Mazzucco et al., 2006; Clark et al., 2012). Our study
identified robust, ERβ-dependent transcriptional regulation of
key genes that are involved in NSPC proliferation and survival.
Important upregulated genes associated with neurogenesis were
Igf2 (along with Igfbp2, Igf1r), Fgf1, Mdk, Prlr, Cdk10, and
Cdkn1c. Insulin-like growth factor 2 is the master regulator of
adult neurogenesis in the subgranular zone (Bracko et al., 2012;
Ouchi et al., 2013). In accord, Igf2 is expressed in progenitor
cells and can regulate cell proliferation and differentiation
in autocrine manner (Ferron et al., 2015). Acidic fibroblast
growth factor maintains proliferation, self-renewal and survival
of NSPC via binding to FGF receptors (Ray and Gage, 2006;
Ma et al., 2009). Midkine enhances the growth and survival
of NSPC (Zou et al., 2006). Prolactin can induce adult
neurogenesis in the hippocampus (Shingo et al., 2003; Larsen
and Grattan, 2012). Regulation of cyclin-dependent kinase
activity affects proliferation and survival of progenitor cells
(Furutachi et al., 2013; Yeh et al., 2013). Of note, downregulation
of Bdnf may also have a strong impact on neurogenesis
(Maisonpierre et al., 1990). These results demonstrate that
the ERβ agonist DPN modulates the transcription of several
major regulators of NSPC proliferation, differentiation, and
survival.
Neuroprotection
Both ERα and ERβ selective agonists exert neuroprotective
effects (Zhao et al., 2004). It is likely that multiple mechanisms
are responsible for the neuroprotective action of ERβ agonists,
and one of the putative mechanisms is myelination. In a
mouse experimental autoimmune encephalomyelitis model,
DPN promotes myelination and protects neurons (Khalaj et al.,
2013). Cellular targets of the ERβ agonist in this case are cells of
the oligodendrocyte lineage. DPN can enhance oligodendrocyte
maturation via klotho signaling (Chen et al., 2013) and via
transcription factors such as Msx1 and Myt1 (Armstrong et al.,
1995). Upregulation ofMbp supports this notion.
DPN robustly activates transcription of klotho. Klotho
expression is detectable in the rat brain including the
hippocampus (Clinton et al., 2013). It protects neurons
against neurodegeneration and oxidative stress via regulation
of members of the redox system (Zeldich et al., 2014). In a
mouse model, inverse correlation was shown between klotho
expression and Alzheimer’s disease phenotype (Kuang et al.,
2014). Neurohormones, such as prolactin and PACAP protect
hippocampal neurons following excitotoxic insult (Morales
et al., 2014) and ischemia (Ohtaki et al., 2006), respectively.
Upregulation of their receptors may potentiate the protective
effects of these neurohormones in the hippocampus.
Another protective mechanism is mediated by transient
receptor potential melastatin 7 (Trpm7) which is downregulated
by DPN. Trpm7 in hippocampal neurons detects extracellular
divalent cations (Wei et al., 2007). Inhibition of Trpm7
expression blocks Trpm7 currents, anoxic Ca++-uptake, ROS
production and anoxic death (Aarts et al., 2003). Suppression
of Trpm7 makes neurons resistant to ischemic death following
brain ischemia (Sun et al., 2009). These data suggest that
downregulation of Trpm7 provides protection against ischemia
after long-term DPN treatment.
It has been demonstrated that some E2 binding sites were
associated with mitochondria in dendritic shafts and spines
of the rat hippocampus (Milner et al., 2008). In accord, E2
modulates the brain mitochondrial proteome (Nilsen et al.,
2007) and regulates oxidativemetabolism inmitochondria (Irwin
et al., 2008). DPN significantly increases the association of
ERβ with mitochondria and enhances protein expression of
ATP synthase in the hippocampus (Irwin et al., 2012). We
found that DPN modestly enhances mRNA expression of ATP
synthase (Atp5l, Atp5e), cytochrome c oxidase VIII (Cox8b) and
some mitochondrial ribosomal protein genes (Mrpl42, Mrps16,
Mrps27) whichmay reflect elevated mitochondrial ATP synthesis
supporting hippocampal functions.
Glutathione peroxidase is the major enzyme to remove the
excess of cytosolic and mitochondrial hydrogen peroxide in
neurons (Desagher et al., 1996). Moderate upregulation of
Gpx1 may provide enhanced protection against hydroxyl radical
formation in the hippocampus.
Modulation of innate immune processes in the brain may also
affect neuroprotection. We have recently published that DPN
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FIGURE 4 | Main effects of ERβ agonist DPN on the hippocampal transcriptome. The alterations in transmitter signaling include the 5-HT, serotonergic; GABA,
GABA-ergic; GLU, glutamatergic; A/NA, adrenergic/noradrenergic; and Ach, cholinergic systems. In the case of peptidergic signaling mechanisms, the local
production of CCK, cholecystokinin and PDYN, prodynorphin is influenced. Various peptide hormone receptors are also regulated by DPN. This group reflects
changes in GAL, galanin; GnRH, gonadotropin-releasing hormone; POMC, pro-opiomelanocortin; PRL, prolactin; CRH, corticotropin-releasing hormone; ANG,
angiotensin; PACAP, pituitary adenylate cyclase-activating polypeptide; and BK, bradykinin neurotransmission/modulation. Growth hormone and trophic factor
production is also highly targeted. A strong regulatory effect is exerted upon certain potassium channels. Synaptic vesicle proteins are also regulated. Transcription
factors show altered expression accompanied with modification of RNA processing, translation and protein synthesis. These complex mechanisms may regulate
neurogenesis and synaptic plasticity and elucidate the molecular background of hippocampus-related physiological processes and symptoms observed after DPN
administration, as summarized partly in Supplementary Table 4.
attenuates mRNA expression of some macrophage-associated
and complement genes in the hippocampus (Sarvari et al., 2014).
Here we showed upregulation of additional immune genes such
as Cd59, Irak1, Cxcr4, and Mif. Upregulation of Cd59 and Irak1
may enhance the protection against homologous complement
lysis (Singhrao et al., 2000) and promote the initial response to
TLR stimulation (Kawagoe et al., 2008), respectively.
Concerning limitations, first we note that pharmacological
approaches in ERβ research are hindered by the moderate
selectivity of ERβ agonists. In a chronic paradigm it seems
reasonable to assume that nonselective actions on ERα may
occur. However, the lack of the hallmark of ERα, namely its
proliferating effect in the uterus, does not support this notion. In
the hippocampus, DPN in part exerts overlapping transcriptional
effects with E2, but there are clear differences (Sarvari et al.,
2015). In addition, DPN distinctly regulates mRNA expression
of some immune genes (Mrc1, Cd163, Cd200r1, Cfb, Cfp) in the
hippocampus (Sarvari et al., 2014). These data support the view
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that at the applied dose DPN selectively activates ERβ. Second,
during the course of treatment DPN modulates the expression
of growth factors, transcriptional regulators and transcription
factors, among others. Therefore, primary and secondary effects
on gene transcription can be hardly identified at the end of
treatment. Third, one of the most responsive genes is Ttr. It is in
accord with the presence of a putative estrogen-response element
within the 5′ flanking region of TTR (Martinho et al., 2013).
Transthyretin is mainly synthesized in the brain by the choroid
plexus, and its expression is regulated by E2 (Tang et al., 2004).
Although mRNA expression of Ttr in the hippocampus (Wang
et al., 2014) and increased level of the protein in the dentate gyrus
during memory consolidation (Monopoli et al., 2011) support
local synthesis, contribution of the choroid plexus can’t be ruled
out since we can’t exclude the presence of traces of choroid plexus
in the dissected hippocampus. Fourth, the transcriptional effects
of ER ligands partly depend on the chemical structure of the
compound (Kuiper et al., 1998). Therefore, it is likely that various
agonists exert slightly different transcriptional effects, i.e., some
genes may show DPN specific regulation.
Summing up, long-term ERβ agonist treatment evokes a
broad array of changes in the hippocampal transcriptome of
middle-aged, ovariectomized rats (Figure 4). A significant set of
DPN-regulated genes was reminiscent to those seen in response
to E2 (Sarvari et al., 2015). The identified basic cellular and
neuronal network mechanisms are utilized in the regulation of
neuronal plasticity, neurogenesis, and neuroprotection in the
hippocampal formation. These events are known to influence
learning, memory, spatial navigation and mood/behavior-related
events (Supplementary Table 4). Based on these results, we
propose that ERβ agonist treatment may represent a safe and
effective estrogen replacement therapy to preserve the integrity
of the hippocampal formation in the postmenopausal period.
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